Yogyakarta, July 8, 2025 – The Faculty of Pharmacy at Gadjah Mada University (UGM) today received a delegation from the Applied Microbiology Research Center of the National Research and Innovation Agency (BRIN). This visit marks an initial step toward exploring and establishing a strategic collaboration in the field of pharmaceutical research and development.
The BRIN delegation, led by Prof. Dr. Puspita Lisdiyanti, an expert in microbiology, was warmly welcomed by the leadership and staff of the UGM Faculty of Pharmacy. The primary agenda for the first day included in-depth discussions on potential research synergies and a direct visit to the Advanced Pharmaceutical Sciences (APS) Laboratory, one of the premier research facilities at the faculty.
Accompanying the BRIN delegation were Akhirta Atikana, M.Sc., and Dr. Gusnaniar, both of whom have strong research track records in applied microbiology and bioprospecting. Participating in the discussion from UGM was Dr. Matin Nuhamunada, S.Si., M.Sc., an expert from the UGM Faculty of Biology, whose expertise is expected to bridge interdisciplinary collaboration.
The BRIN delegation was invited to tour the facilities and technology at the APS Laboratory. This lab visit was intended to provide a concrete overview of the research capabilities possessed by the UGM Faculty of Pharmacy, allowing for a clearer identification of the most feasible cooperation schemes to implement.
This engagement also supports the achievement of several Sustainable Development Goals (SDGs). The cooperation is a tangible manifestation of SDG 17 (Partnerships for the Goals), uniting the strengths of an academic institution and a government research agency. This synergy is directly aimed at strengthening SDG 9 (Industry, Innovation, and Infrastructure) by promoting applied research and pharmaceutical innovation that can enhance national technological capabilities. Ultimately, the outcomes of this collaboration are expected to contribute significantly to SDG 3 (Good Health and Well-being) through the potential discovery of new medicinal compounds from Indonesia’s biological resources, which can be used to develop more effective and affordable therapies for the wider community.
